Figure S11 from IFNγ-Induced PD-L1+MHCII+ Macrophages and Tim-3+ Tumor-Reactive CD8+ T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice
Gabrilo J., Vande Velde S., Henin C., Denanglaire S., Azouz A., Boon L., Van den Eynde BJ., Moser M., Goriely S., Leo O.
Clinical significance of PD-L1+ MHC II+ myeloid subset (M_3 cluster) in response to anti-PD-1 therapy